These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6875818)

  • 41. Use of hydrophobins in formulation of water insoluble drugs for oral administration.
    Haas Jimoh Akanbi M; Post E; Meter-Arkema A; Rink R; Robillard GT; Wang X; Wösten HA; Scholtmeijer K
    Colloids Surf B Biointerfaces; 2010 Feb; 75(2):526-31. PubMed ID: 19836932
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Finding T
    Han YR; Lee PI; Pang KS
    Drug Metab Dispos; 2018 Nov; 46(11):1796-1804. PubMed ID: 30135243
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mathematical considerations in the estimation of peak drug concentrations under uniform and nonuniform dosing conditions.
    Hull JH
    J Clin Pharmacol; 1980; 20(11):644-51. PubMed ID: 7229111
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ethanol-drug absorption interaction: potential for a significant effect on the plasma pharmacokinetics of ethanol vulnerable formulations.
    Lennernäs H
    Mol Pharm; 2009; 6(5):1429-40. PubMed ID: 19655809
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative bioavailability of sulfamethoxazole in co-trimoxazole suspensions containing different thickness agents.
    Marchetti JM; Shuhama IK; Bentley MV; Lara EH
    Boll Chim Farm; 1999 Oct; 138(9):461-4. PubMed ID: 10682404
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of efficiency of insulin suppository formulations containing sodium salicylate or sodium cholate in insulin dependent diabetic patients.
    Hosny EA; Al-Marzouki ZM; Metwally ME; Souaida MY; Alshaik AR
    Boll Chim Farm; 2003 Oct; 142(8):361-6. PubMed ID: 15040468
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Subcutaneous administration of nano- and microsuspensions of poorly soluble compounds to rats.
    Sigfridsson K; Lundqvist A; Strimfors M
    Drug Dev Ind Pharm; 2014 Apr; 40(4):511-8. PubMed ID: 23557177
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Studies on the metabolic fate of isepamicin sulfate (HAPA-B). I. Absorption, distribution, metabolism and excretion in rats].
    Suzuki T; Serizawa K; Somiya Y; Shirai M; Endo S; Morishita M
    Jpn J Antibiot; 1987 Jan; 40(1):188-201. PubMed ID: 3586328
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Physicochemical basis of increased bioavailability of a poorly water-soluble drug following oral administration as organic solutions.
    Serajuddin AT; Sheen PC; Mufson D; Bernstein DF; Augustine MA
    J Pharm Sci; 1988 Apr; 77(4):325-9. PubMed ID: 3379591
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Model building in pharmacokinetics/Part V: Simulation of blood level curves following repetitive dosing and their experimental verification (author's transl)].
    Hammer R; Bozler G; Heinzel G; Koss FW
    Arzneimittelforschung; 1977; 27(4a):928-31. PubMed ID: 577860
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Route of administration and drug metabolism.
    Gibaldi M; Feldman S
    Eur J Pharmacol; 1972 Sep; 19(3):323-9. PubMed ID: 4640856
    [No Abstract]   [Full Text] [Related]  

  • 52. The ability of two in vitro lipolysis models reflecting the human and rat gastro-intestinal conditions to predict the in vivo performance of SNEDDS dosing regimens.
    Siqueira Jørgensen SD; Al Sawaf M; Graeser K; Mu H; Müllertz A; Rades T
    Eur J Pharm Biopharm; 2018 Mar; 124():116-124. PubMed ID: 29288805
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vivo approach to determine the route of optimal drug absorption in rats.
    Lhote O; Decoodt A; Moulin A; Dufour A
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():43-6. PubMed ID: 1820918
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of the absorption kinetics of macromolecules following intradermal and subcutaneous administration.
    Milewski M; Manser K; Nissley BP; Mitra A
    Eur J Pharm Biopharm; 2015 Jan; 89():134-44. PubMed ID: 25460581
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A simple linear model for the simulation of plasma concentration-time curves based on the two-compartment open model.
    Mizuta E
    Chem Pharm Bull (Tokyo); 1984 Mar; 32(3):1096-105. PubMed ID: 6744482
    [No Abstract]   [Full Text] [Related]  

  • 56. Model-independent steady-state plasma level predictions in autonomic nonlinear pharmacokinetics I: Derivation and theoretical analysis.
    Veng-Pedersen P
    J Pharm Sci; 1984 Jun; 73(6):761-5. PubMed ID: 6737260
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rapid compartment- and model-independent estimation of times required to attain various fractions of steady-state plasma level during multiple dosing of drugs obeying superposition principle and having various absorption or infusion kinetics.
    Chiou WL
    J Pharm Sci; 1979 Dec; 68(12):1546-7. PubMed ID: 529049
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetic analysis of concentration data of drugs with irregular absorption profiles using multi-fraction absorption models.
    Murata K; Noda K; Kohno K; Samejima M
    J Pharm Sci; 1987 Feb; 76(2):109-13. PubMed ID: 3572746
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Subarachnoid local anesthetic block does not affect morphine absorption from paired intramuscular and subcutaneous injection sites in the elderly patient.
    Ronald AL; Docherty D; Broom J; Chambers WA
    Anesth Analg; 1993 Apr; 76(4):778-82. PubMed ID: 8466016
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Using pharmacokinetics in drug therapy II: Rapid estimates of dosage regimens and blood levels without knowledge of pharmacokinetic variables.
    Schumacher GE; Griener JC
    Am J Hosp Pharm; 1978 Apr; 35(4):454-9. PubMed ID: 645719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.